Recent advances in the manufacturing technologies have
prompted pharmaceutical companies to consider shifting from the traditional
multi-step, batch manufacturing processes to faster, and relatively more
efficient continuous manufacturing
Roots Analysis is pleased to announce the publication of its recent study,
titled, “Manufacturing Market Continuous
(Small Molecules and Biologics), 2020 – 2030.”
The report features an extensive study of the
current market landscape and future opportunities for companies with
capabilities in continuous manufacturing (both innovator companies with
in-house expertise and contract manufacturers). It features an in-depth
analysis, highlighting the capabilities of various stakeholders engaged in this
domain. In addition to other elements, the study includes:
§ A
detailed assessment of the overall landscape of companies with capabilities for
continuous manufacturing
§
Elaborate profiles of some of the key contract
manufacturers active in the pharmaceutical and biopharmaceutical continuous
manufacturing market
§
An analysis of the various partnerships related to
continuous manufacturing, which have been established since 2013
§
An analysis of the expansions related to continuous manufacturing,
which have been established since 2013
§
An estimate of the global, continuous manufacturing
capacity, based on the capacities of various industry stakeholders (as
available on their respective company websites).
§
A study of the various grants that have been awarded to
research institutes engaged in projects related to continuous manufacturing,
between 2014 and 2019
§
An in-depth analysis of the various patents that have been
filed / granted related to continuous manufacturing till 2019
§ Initiatives taken by the leading pharmaceutical companies
(in terms of revenues), covering both partnered as well as in-house projects.
§ A review of the companies offering modular facilities /
modular cleanrooms
§ A case study of the companies offering technologies / equipment
§ A case study on the roadmap for the adoption of continuous
manufacturing technique
§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)
§ Purpose
of Manufacturing
§
In-House
§
Contract service
§ Scale
of Operation
§
Commercial
§
Preclinical /
Clinical
§ Type
of Continuous Manufacturing related Service
§ API
Manufacturing
§ End
Product manufacturing
§ Type
of Drug Molecule
§
Biologic
§
Small Molecule
§ Type
of dosage form
§
Solid
§
Liquid
§ Key
Geographical Regions
§
North America
§
Europe
§
Asia Pacific
To
Request for sample report - https://www.rootsanalysis.com/reports/308/request-sample.html
§
Transcripts of interviews held with the following senior
level representatives of stakeholder companies
§
Andrea Adamo, Founder
and Chief Executive Officer, Zaiput Flow technologies
§
Bayan Takizawa, Co-Founder
and Chief Business Officer, CONTINUUS Pharmaceuticals
§
Nick Thomson, Senior
Director Chemical Research and Development, Pfizer
§
Himanshu Gadgil, Director
and Chief Scientific Officer, Enzene Biosciences
§
Eric Fang, Chief
Scientific Officer, Snapdragon Chemistry)
§
Ian Houson, Technical
Project Manager, Continuous Manufacturing and Crystallization, University of
Strathclyde
Key
companies covered in the report
§
AbbVie Contract
Manufacturing
§
Ajinomoto Bio-Pharma
Services
§
Almac
§
Boehringer Ingelheim
BioXcellence
§
Cambrex
§
CordonPharma
§
Hovione
§
Kaneka
§
Lonza
§
Patheon
§
SK biotek
§
WuXi AppTec
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
Other Offerings
1.
Pharmaceutical Contract Manufacturing
Market (2nd Edition), 2018-2028
2.
Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
3.
China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
4.
China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment